Abstract PS13-33: Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecanHeather Moore, Kelly Westbrook, Amy Guisinger et al.|Cancer Research|2021Cited by 4